As we reported last week, the Northern District of West Virginia court has ordered an expedited trial in Regeneron’s aflibercept BPCIA case against Mylan. As required by the court’s scheduling order, on October 28, Regeneron identified six patents for the first phase of the litigation. Regeneron also agreed that “it will…